Skip to content
You can now search across every topic, entity and event.What's new
Bundibugyo ebolavirus
ConceptCD

Bundibugyo ebolavirus

Rare Ebola species with no licensed vaccine or treatment, now causing its largest recorded outbreak.

On 20 July WHO said over 80% of new Ituri cases now evade contact tracing entirely, as the outbreak became the third-largest Ebola epidemic of any species on record with no licensed vaccine or treatment yet available.

Last refreshed: 31 July 2026 · Appears in 1 active topic

Key Question

Why has exit screening failed to contain the first Ebola case to reach Europe?

Timeline for Bundibugyo ebolavirus

#12 31 Jul
#12 27 Jul
#12 27 Jul

Most Ebola deaths never reach a ward

Pandemics and Biosecurity
#11 20 Jul

80% of Ebola cases now untraced

Pandemics and Biosecurity
#11 17 Jul
View full timeline →

Background

Bundibugyo ebolavirus is one of six recognised species in the genus Orthoebolavirus, first identified in 2007 during an outbreak in Bundibugyo District, western Uganda (131 cases, 39 deaths), with a second outbreak in Isiro, eastern DRC in 2012 (38 cases, 13 deaths, about 34% case fatality). Before 2026, those two outbreaks were the species' entire clinical record.

The virus belongs to the Filovirus family alongside Marburg virus and targets endothelial and immune cells. Its glycoprotein differs enough from Zaire ebolavirus that Ervebo, Inmazeb and Ebanga, the licensed Zaire-specific vaccine and treatments, give no cross-protection. WHO's R&D Blueprint Filovirus roadmap named the non-Zaire gap a priority three months before the 2026 outbreak began.

WHO declared a Public Health Emergency of International Concern for the DRC and Uganda outbreak on 17 May 2026, its first ever for this species. The outbreak has since become the largest Bundibugyo epidemic on record by a wide margin and the third-largest Ebola outbreak of any species, exposing a structural gap: no licensed medical countermeasure exists for a species that has now caused mass casualties.

Key Issues
Ituri outbreak

Contact tracing has collapsed in Ituri

By 20 July, WHO said more than 80% of new Bundibugyo cases in DR Congo were emerging outside any known contact chain, as the outbreak reached 2,344 confirmed cases and 930 deaths, a roughly 39.7% case-fatality ratio. Tedros called it the third-largest Ebola outbreak of any species on record, trailing only Zaire ebolavirus's two largest epidemics.

The untraced share matters because it means the outbreak is now spreading faster than responders can map it: a traced contact can be isolated before symptoms begin, but an untraceable case is found only once it is already infectious. That shift, not the raw case count, pushed WHO's language from containment towards acknowledging that transmission has outrun surveillance.

Frontline workforce

Ebola is killing its own responders

Health-worker infections in the Bundibugyo outbreak more than tripled between mid-June and 11 July, from 34 confirmed cases to 112, with 35 of those workers dead; Africa CDC formally appealed for better protective equipment and psychosocial support.

Two days earlier, front-line staff in Ituri Province had walked off the job or threatened to strike over unpaid hazard pay and delayed salaries, even as donors pledged hundreds of millions in outbreak funding. The workforce treating patients has become a second front in the epidemic, stripping case-finding and isolation capacity from a response that already cannot keep pace.

Common Questions

Contact tracing has collapsed in Ituri

Has the Bundibugyo Ebola outbreak been contained in Uganda?
Uganda discharged its last confirmed patient on 16 July 2026 and opened a 42-day countdown to declare its own outbreak over, with a final tally of 20 cases and 2 deaths, even as DRC's Ituri epidemic keeps growing.Source: WHO
What is the largest Ebola outbreak ever recorded?
Zaire ebolavirus's 2014-16 West Africa epidemic remains largest at roughly 28,000 cases; the ongoing Bundibugyo outbreak is third-largest of any species, at 2,344 confirmed cases as of 20 July 2026.Source: WHO
How does the 2026 Bundibugyo Ebola outbreak's death rate compare with past outbreaks?
Its roughly 39.7% case-fatality ratio as of 20 July 2026 sits between Uganda's 2007 discovery outbreak (30%) and DRC's 2012 Isiro outbreak (50%).Source: WHO/ECDC
How does the 2026 Ituri Bundibugyo outbreak compare to previous outbreaks?
By 24 June 2026 the outbreak had reached 1,094 confirmed cases and 277 deaths — more than seven times the size of the 2007 Bundibugyo discovery outbreak (131 cases), making it the largest Bundibugyo outbreak on record. The first case outside Africa was confirmed in France on 24 June.Source: WHO / Africa CDC
Why has Ebola spread to France from the DRC outbreak?
A French humanitarian doctor who spent 31 days treating patients in Ituri Province, DRC, departed on 19 June 2026 without symptoms and tested positive in France on 24 June. Exit-screening caught no signs of illness at departure, confirming that asymptomatic departure is a fundamental ceiling for airport screening as a containment tool.Source: WHO / MSF
Is there a vaccine being developed for Bundibugyo Ebola?
As of June 2026, no licensed vaccine exists for Bundibugyo ebolavirus. A $62 million Coalition announced on 1 June 2026 aims to fast-track three vaccine candidates — a ChAdOx-platform and an rVSV-platform candidate are the furthest along — but both require at least 12 to 18 months before human dosing can begin.Source: STAT News, 1 June 2026; event ID:3825

Reference

When was Bundibugyo ebolavirus first discovered?
Bundibugyo ebolavirus was first identified in 2007 during an outbreak in Bundibugyo District, western Uganda, which produced 131 cases and 39 deaths. A second outbreak occurred in 2012 in Isiro, eastern DRC, with 38 cases and 13 deaths. The 2026 Ituri outbreak is by FAR the largest in the species' recorded history.Source: WHO species history
Why has there never been an Ebola treatment for the Bundibugyo strain?
Bundibugyo has caused only three outbreaks before 2026, totalling fewer than 170 cases over 19 years. The low case count reduced the commercial and scientific incentive to fund Bundibugyo-specific clinical trials. The WHO R&D Blueprint Filovirus roadmap named this gap in Q1 2026, three months before the current outbreak.Source: WHO R&D Blueprint; CIDRAP; CDC panel transcript, 15 May 2026
Is there a vaccine or treatment for Bundibugyo Ebola?
No. There is no approved vaccine or treatment specifically for Bundibugyo ebolavirus. Approved Ebola products — Ervebo (vaccine), Inmazeb and Ebanga (treatments) — all target Zaire ebolavirus. A WHO-sponsored trial of MBP134 plus REGN3479 is the first authorised intervention in the 2026 outbreak.Source: WHO DON607
Where has the current Bundibugyo Ebola outbreak spread outside Africa?
A French doctor tested positive after returning home on 24 June, and a US aid worker was evacuated to Germany on 13 July; there has been no sustained transmission outside DRC and Uganda.Source: WHO
Why is the Bundibugyo Ebola outbreak still not under control despite funding?
Isolation of confirmed cases has kept slipping, down to roughly 31% by 20 July 2026 (from 39% in mid-July), even as funding kept arriving; WHO said over 80% of new cases now arise outside any known contact chain. Healthcare-worker infections more than tripled to 112 confirmed cases with 35 deaths, showing the constraint has shifted from money and diagnostics to a collapsing frontline workforce.Source: Africa CDC, 11 July 2026
How deadly is Bundibugyo Ebola compared to the Zaire strain?
The lab-confirmed case-fatality rate for the 2026 outbreak is approximately 14%, lower than Zaire ebolavirus's historical average of around 50%. However, with a suspected-to-confirmed ratio of roughly 6.8 to one, many deaths go unsampled; the true rate is likely FAR higher. Imperial College London estimated 30-40% in prior Bundibugyo outbreaks.Source: WHO DON605; Imperial College London
Why can't doctors use existing Ebola drugs to treat the current outbreak?
All licensed Ebola treatments (Inmazeb, Ebanga) and the Ervebo vaccine target only Zaire ebolavirus. The 2026 outbreak is caused by Bundibugyo ebolavirus, which has a sufficiently different glycoprotein that these products do not cross-protect. A new WHO-sponsored trial is underway with MBP134 and REGN3479.Source: WHO R&D Blueprint
Source Material